Vous êtes sur la page 1sur 1

39203

Rules and Regulations Federal Register


Vol. 71, No. 133

Wednesday, July 12, 2006

This section of the FEDERAL REGISTER SUPPLEMENTARY INFORMATION: Since this change has no effect on the
contains regulatory documents having general special conditions, the remainder of the
applicability and legal effect, most of which Need for Correction
document, which includes the special
are keyed to and codified in the Code of The FAA published a document on condition portion, will not be changed.
Federal Regulations, which is published under June 16, 2006 (71 FR 34789), that issued
50 titles pursuant to 44 U.S.C. 1510. Issued in Kansas City, Missouri on June 23,
final special conditions with a request 2006.
The Code of Federal Regulations is sold by
for comments. In the background, the
John Colomy,
the Superintendent of Documents. Prices of sentence ‘‘The Cessna 510 will be
approved under TC No. A24CE’’ Acting Manager, Small Airplane Directorate,
new books are listed in the first FEDERAL Aircraft Certification Service.
REGISTER issue of each week. appears. However, this will not be the
type certificate number for the airplane, [FR Doc. E6–10469 Filed 7–11–06; 8:45 am]
and this sentence is removed from the BILLING CODE 4910–13–P

DEPARTMENT OF TRANSPORTATION background to correct the error. There


will be no change to the special
Federal Aviation Administration conditions. DEPARTMENT OF HEALTH AND
Correction of Publication HUMAN SERVICES
14 CFR Part 23
Accordingly, the background of the Food and Drug Administration
[Docket No. CE252, Special Condition No. special conditions is revised to remove
23–192–SC] the sentence, ‘‘The Cessna 510 will be 21 CFR Part 520
Special Conditions; Cessna Aircraft approved under TC No. A24CE’’ from
Company Model 510 Airplane; Full the document. Oral Dosage Form New Animal Drugs;
Authority Digital Engine Control Comments Invited Clindamycin Capsules and Tablets
(FADEC) System Interested persons are invited to AGENCY: Food and Drug Administration,
AGENCY: Federal Aviation participate in the making of these HHS.
Administration (FAA), DOT. special conditions by submitting such ACTION: Final rule.
written data, views, or arguments as
ACTION: Final special conditions; request
they may desire. Communications SUMMARY: The Food and Drug
for comments; correction.
should identify the regulatory docket or Administration (FDA) is amending the
SUMMARY: On June 16, 2006, we notice number and be submitted in animal drug regulations to reflect
published a document on special duplicate to the address specified above. approval of a supplemental abbreviated
conditions for Cessna Aircraft Company All communications received on or new animal drug application (ANADA)
on the Model 510 airplane for full before the closing date for comments filed by Virbac AH, Inc. The
authority digital engine control system. will be considered by the Administrator. supplemental ANADA provides for an
There was an error in the background of The proposals described in this notice expanded dose range and revised
the document in reference to the future may be changed in light of the wording of indications for the oral use
type certificate number. This notice comments received. All comments of clindamycin hydrochloride tablets in
removes that sentence from the received will be available in the Rules dogs for the treatment of certain
background; no change to the special Docket for examination by interested bacterial diseases.
conditions portion is necessary. persons, both before and after the DATES: This rule is effective July 12,
DATES: Comments must be received on
closing date for comments. A report 2006.
or before July 17, 2006. summarizing each substantive public
FOR FURTHER INFORMATION CONTACT:
contact with FAA personnel concerning
ADDRESSES: Comments on this proposal Daniel A. Benz, Center for Veterinary
this rulemaking will be filed in the
may be mailed in duplicate to: Federal docket. Persons wishing the FAA to Medicine (HFV–104), Food and Drug
Aviation Administration, Regional acknowledge receipt of their comments Administration, 7500 Standish Pl.,
Counsel, ACE–7, Attention: Rules submitted in response to this notice Rockville, MD 20855, 301–827–0223, e-
Docket Clerk, Docket No. CE252, Room must include with those comments a mail: daniel.benz@fda.hhs.gov.
506, 901 Locust, Kansas City, Missouri self-addressed stamped postcard on SUPPLEMENTARY INFORMATION: Virbac
64106. All comments must be marked: which the following statement is made: AH, Inc., 3200 Meacham Blvd., Ft.
Docket No. CE252. Comments may be ‘‘Comments to Docket No. CE252.’’ The Worth, TX 76137, filed a supplement to
inspected in the Rules Docket postcard will be date stamped and ANADA 200–316 for CLINITABS
weekdays, except Federal holidays, returned to the commenter. (clindamycin hydrochloride) tablets for
between 7:30 a.m. and 4 p.m. the treatment of certain bacterial
FOR FURTHER INFORMATION CONTACT: Background diseases in dogs. The supplemental
Peter L. Rouse, Aerospace Engineer, The original background of the special ANADA provides for an expanded dose
Standards Office (ACE–110), Small conditions contained the following range and revised wording of
Airplane Directorate, Aircraft sentence: ‘‘The Cessna 510 will be indications. The supplemental ANADA
wwhite on PROD1PC61 with RULES

Certification Service, Federal Aviation approved under TC No. A24CE.’’ This is approved as of June 2, 2006, and the
Administration, Room 301, 901 Locust type certificate number is incorrect, and regulations are amended in 21 CFR
Street, Kansas City, Missouri 64106; the sentence is removed from the 520.446 to reflect the approval and a
telephone (816) 329–4135. background of the special conditions. current format.

VerDate Aug<31>2005 18:11 Jul 11, 2006 Jkt 208001 PO 00000 Frm 00001 Fmt 4700 Sfmt 4700 E:\FR\FM\12JYR1.SGM 12JYR1

Vous aimerez peut-être aussi